Chemoinformaics analysis of 8-Methoxy-6,7-methylenedioxycoumarin
| Molecular Weight | 220.18 | nRot | 1 |
| Heavy Atom Molecular Weight | 212.116 | nRig | 16 |
| Exact Molecular Weight | 220.037 | nRing | 3 |
| Solubility: LogS | -2.738 | nHRing | 2 |
| Solubility: LogP | 1.24 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 11 |
| nHA | 5 | APOL | 27.7143 |
| nHD | 0 | BPOL | 15.8377 |
| QED | 0.682 |
| Synth | 2.468 |
| Natural Product Likeliness | 1.299 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.065 |
| Pgp-sub | 0 |
| HIA | 0.002 |
| CACO-2 | -4.579 |
| MDCK | 0.0000309 |
| BBB | 0.149 |
| PPB | 0.813274 |
| VDSS | 1.025 |
| FU | 0.18358 |
| CYP1A2-inh | 0.99 |
| CYP1A2-sub | 0.83 |
| CYP2c19-inh | 0.795 |
| CYP2c19-sub | 0.345 |
| CYP2c9-inh | 0.168 |
| CYP2c9-sub | 0.87 |
| CYP2d6-inh | 0.822 |
| CYP2d6-sub | 0.79 |
| CYP3a4-inh | 0.822 |
| CYP3a4-sub | 0.197 |
| CL | 12.627 |
| T12 | 0.603 |
| hERG | 0.065 |
| Ames | 0.468 |
| ROA | 0.062 |
| SkinSen | 0.361 |
| Carcinogencity | 0.958 |
| EI | 0.207 |
| Respiratory | 0.239 |
| NR-Aromatase | 0.222 |
| Antiviral | No |
| Prediction | 0.667228 |